T3 N1 M0 rectal cancer: optimal initial management is total neoadjuvant therapy

被引：0
|
作者：
Nilsson, Per J. [1 ,2 ]
机构：
[1] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[2] Karolinska Inst, Dept Mol Med & Surg, Euegeniav 6, Hotellet pl 2, SE-17176 Stockholm, Sweden
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷 / 01期
关键词：
PREOPERATIVE CHEMORADIOTHERAPY; OPEN-LABEL; CHEMOTHERAPY;
D O I：
10.1093/bjs/znad322
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer
    Pericay, C.
    Serra-Aracil, X.
    Ocana-Rojas, J.
    Mora-Lopez, L.
    Dotor, E.
    Casalots, A.
    Pisa, A.
    Saigi, E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (07): : 666 - 671
  • [32] Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer
    C. Pericay
    X. Serra-Aracil
    J. Ocaña-Rojas
    L. Mora-López
    E. Dotor
    A. Casalots
    A. Pisa
    E. Saigí
    Clinical and Translational Oncology, 2016, 18 : 666 - 671
  • [33] PROGRESSION IN UNTREATED CARCINOMA OF THE PROSTATE METASTATIC TO REGIONAL LYMPH-NODES (STAGE T0 4,N1 TO 3,M0,D1)
    DAVIDSON, PJT
    HOP, W
    KURTH, KH
    FOSSA, SD
    WAEHRE, H
    SCHRODER, FH
    JOURNAL OF UROLOGY, 1995, 154 (06): : 2118 - 2122
  • [34] Omission of neoadjuvant radiotherapy for clinical T2/N1 and T3N0/1 middle and low rectal cancers with safe circumferential resection margins
    Lee, Kyung-Ha
    Kim, Jin-Soo
    Kim, Ji-Yeon
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2022, 102 (05) : 281 - 288
  • [35] Effects of magnetic resonance imaging prognostic factors on neoadjuvant therapy in T3 or N+ rectal cancer: A retrospective cohort study
    Xie, Hao
    Zeng, Ziwei
    Cai, Yonghua
    Ma, Decai
    Lei, Dongxu
    Ye, Fujin
    Luo, Shuangling
    Xiong, Li
    Li, Wenxin
    Liang, Zhenxing
    Zheng, Xiaobin
    Huang, Liang
    Liu, Huashan
    Kang, Liang
    JOURNAL OF EVIDENCE BASED MEDICINE, 2023, 16 (04) : 442 - 445
  • [36] Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2-T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)
    Serra-Aracil, X.
    Pericay, C.
    Golda, T.
    Mora, L.
    Targarona, E.
    Delgado, S.
    Reina, A.
    Vallribera, F.
    Enriquez-Navascues, J. M.
    Serra-Pla, S.
    Garcia-Pacheco, J. C.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2018, 33 (02) : 241 - 249
  • [37] T3 Subclassification With EMD/Mesorectum Ratio Predicts Neoadjuvant Chemoradiation Outcome in T3 Rectal Cancer Patients
    Shen, L.
    Sun, Y.
    Tong, T.
    Zhang, H.
    Liang, L.
    Deng, W.
    Li, G.
    Zhu, J.
    Zhang, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E156 - E156
  • [38] Fluorescence in situ hybridization (FISH) analysis of c-myc amplification in Stage T3 N0 M0 prostate cancer in Japanese patients
    Sato, H
    Hachiya, T
    Ishida, H
    Okada, K
    Takimoto, Y
    JOURNAL OF UROLOGY, 2003, 169 (04): : 161 - 162
  • [39] T3N0 Rectal Cancer
    Chalmers, Zachary R.
    Roberts, Hannah J.
    Wo, Jennifer Y.
    CANCER JOURNAL, 2024, 30 (04): : 232 - 237
  • [40] The quandary of N0 disease after neoadjuvant therapy for rectal cancer
    Madariaga, Maria Lucia L.
    Berger, David L.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2012, 3 (04) : 299 - 300
12345